Editorial Advisory Board

The Pharmaceutical Manufacturing Editorial Advisory Board is a group of distinguished individuals assembled to assist our publication in fulfilling its editorial mission to provide professionals the tools they need to deliver authentic innovation in today's pharma environment, presented in a way that is straightforward and unpretentious.


Pharmaceutical Manufacturing Announces Updated Editorial Advisory Board
The Good, the Bad & the Donald: CPhI Worldwide's 2017 Pharma Predictions


Jim Agalloco, President, Agalloco & Associates
Bikash Chatterjee, President, pharmatech associates
Emil Ciurczak, President, Doramaxx Consulting
Robert Dream, Managing Director, HDR Company
Barry Holtz, President, iBio
Eric Langer, President, BioPlan Associates
Ivan Lugo, Executive Director, INDUNIV
Girish Malhotra, President, EPCOT International
Rich Myer, Director of Business Development, Avara Pharmaceutical Services 
Gary Ritchie, President, GER COMPLIANCE
Mike Tousey, CEO, Techceuticals 


Jim Agalloco

Product Focus: Process Analytical Technologies
Henry Ford Had It Right
From ‘I Think I Can’ to ‘I Knew I Could’
Wish List, Predictions for 2017
Pros and Cons of Biosimilars

Robert Dream
Biopharma's Flexible Imperative

Barry Holtz
Planting the Seed for Speed
Plant Transient Technology Expedites Scale-Up

Eric Langer
Biopharma Market: An Inside Look
Biopharma CMO Consolidation: Opportunity or Obstacle?
Downstream Gears Up

Ivan Lugo
Battered but Unbroken

Girish Malhotra
Keeping Innovation in Our Hands
Financial Justification in Pharma
Bold Steps Needed to Alleviate Drug Shortages and Price Hikes?
Pharma’s Landscape is Going to Look a Lot Different in 2026
How to Justify Innovation and QbD in Manufacturing

Mike Tousey
A Better Batch
Why Cookies Crumble
Long Live OSD